Copyright Reports & Markets. All rights reserved.

Global Precision Cancer Tests Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Precision Cancer Tests Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Imaging
      • 1.4.3 In Vitro Diagnostic
      • 1.4.4 Others
    • 1.5 Market by Application
      • 1.5.1 Global Precision Cancer Tests Market Share by Application (2014-2025)
      • 1.5.2 Cancer Research Centers
      • 1.5.3 Cancer Hospital
      • 1.5.4 Surgical Centers
      • 1.5.5 Clinics
      • 1.5.6 Others
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Precision Cancer Tests Market Size
    • 2.2 Precision Cancer Tests Growth Trends by Regions
      • 2.2.1 Precision Cancer Tests Market Size by Regions (2014-2025)
      • 2.2.2 Precision Cancer Tests Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Opportunities

    3 Market Share by Key Players

    • 3.1 Precision Cancer Tests Market Size by Manufacturers
      • 3.1.1 Global Precision Cancer Tests Revenue by Manufacturers (2014-2019)
      • 3.1.2 Global Precision Cancer Tests Revenue Market Share by Manufacturers (2014-2019)
      • 3.1.3 Global Precision Cancer Tests Market Concentration Ratio (CR5 and HHI)
    • 3.2 Precision Cancer Tests Key Players Head office and Area Served
    • 3.3 Key Players Precision Cancer Tests Product/Solution/Service
    • 3.4 Date of Enter into Precision Cancer Tests Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Precision Cancer Tests Market Size by Type (2014-2019)
    • 4.2 Global Precision Cancer Tests Market Size by Application (2014-2019)

    5 United States

    • 5.1 United States Precision Cancer Tests Market Size (2014-2019)
    • 5.2 Precision Cancer Tests Key Players in United States
    • 5.3 United States Precision Cancer Tests Market Size by Type
    • 5.4 United States Precision Cancer Tests Market Size by Application

    6 Europe

    • 6.1 Europe Precision Cancer Tests Market Size (2014-2019)
    • 6.2 Precision Cancer Tests Key Players in Europe
    • 6.3 Europe Precision Cancer Tests Market Size by Type
    • 6.4 Europe Precision Cancer Tests Market Size by Application

    7 China

    • 7.1 China Precision Cancer Tests Market Size (2014-2019)
    • 7.2 Precision Cancer Tests Key Players in China
    • 7.3 China Precision Cancer Tests Market Size by Type
    • 7.4 China Precision Cancer Tests Market Size by Application

    8 Japan

    • 8.1 Japan Precision Cancer Tests Market Size (2014-2019)
    • 8.2 Precision Cancer Tests Key Players in Japan
    • 8.3 Japan Precision Cancer Tests Market Size by Type
    • 8.4 Japan Precision Cancer Tests Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Precision Cancer Tests Market Size (2014-2019)
    • 9.2 Precision Cancer Tests Key Players in Southeast Asia
    • 9.3 Southeast Asia Precision Cancer Tests Market Size by Type
    • 9.4 Southeast Asia Precision Cancer Tests Market Size by Application

    10 India

    • 10.1 India Precision Cancer Tests Market Size (2014-2019)
    • 10.2 Precision Cancer Tests Key Players in India
    • 10.3 India Precision Cancer Tests Market Size by Type
    • 10.4 India Precision Cancer Tests Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Precision Cancer Tests Market Size (2014-2019)
    • 11.2 Precision Cancer Tests Key Players in Central & South America
    • 11.3 Central & South America Precision Cancer Tests Market Size by Type
    • 11.4 Central & South America Precision Cancer Tests Market Size by Application

    12 International Players Profiles

    • 12.1 Abbott
      • 12.1.1 Abbott Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Precision Cancer Tests Introduction
      • 12.1.4 Abbott Revenue in Precision Cancer Tests Business (2014-2019)
      • 12.1.5 Abbott Recent Development
    • 12.2 BD
      • 12.2.1 BD Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Precision Cancer Tests Introduction
      • 12.2.4 BD Revenue in Precision Cancer Tests Business (2014-2019)
      • 12.2.5 BD Recent Development
    • 12.3 Bio-Rad
      • 12.3.1 Bio-Rad Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Precision Cancer Tests Introduction
      • 12.3.4 Bio-Rad Revenue in Precision Cancer Tests Business (2014-2019)
      • 12.3.5 Bio-Rad Recent Development
    • 12.4 Cynvenio Biosystems
      • 12.4.1 Cynvenio Biosystems Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Precision Cancer Tests Introduction
      • 12.4.4 Cynvenio Biosystems Revenue in Precision Cancer Tests Business (2014-2019)
      • 12.4.5 Cynvenio Biosystems Recent Development
    • 12.5 Foundation Medicine
      • 12.5.1 Foundation Medicine Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Precision Cancer Tests Introduction
      • 12.5.4 Foundation Medicine Revenue in Precision Cancer Tests Business (2014-2019)
      • 12.5.5 Foundation Medicine Recent Development
    • 12.6 Genomic Health
      • 12.6.1 Genomic Health Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Precision Cancer Tests Introduction
      • 12.6.4 Genomic Health Revenue in Precision Cancer Tests Business (2014-2019)
      • 12.6.5 Genomic Health Recent Development
    • 12.7 Illumina
      • 12.7.1 Illumina Company Details
      • 12.7.2 Company Description and Business Overview
      • 12.7.3 Precision Cancer Tests Introduction
      • 12.7.4 Illumina Revenue in Precision Cancer Tests Business (2014-2019)
      • 12.7.5 Illumina Recent Development
    • 12.8 Myriad Genetics
      • 12.8.1 Myriad Genetics Company Details
      • 12.8.2 Company Description and Business Overview
      • 12.8.3 Precision Cancer Tests Introduction
      • 12.8.4 Myriad Genetics Revenue in Precision Cancer Tests Business (2014-2019)
      • 12.8.5 Myriad Genetics Recent Development
    • 12.9 NanoString Technologies
      • 12.9.1 NanoString Technologies Company Details
      • 12.9.2 Company Description and Business Overview
      • 12.9.3 Precision Cancer Tests Introduction
      • 12.9.4 NanoString Technologies Revenue in Precision Cancer Tests Business (2014-2019)
      • 12.9.5 NanoString Technologies Recent Development
    • 12.10 QIAGEN
      • 12.10.1 QIAGEN Company Details
      • 12.10.2 Company Description and Business Overview
      • 12.10.3 Precision Cancer Tests Introduction
      • 12.10.4 QIAGEN Revenue in Precision Cancer Tests Business (2014-2019)
      • 12.10.5 QIAGEN Recent Development
    • 12.11 Randox Laboratories
    • 12.12 Roche
    • 12.13 Philips
    • 12.14 Thermo Fisher Scientific

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Regions
    • 13.2 United States
    • 13.3 Europe
    • 13.4 China
    • 13.5 Japan
    • 13.6 Southeast Asia
    • 13.7 India
    • 13.8 Central & South America
    • 13.9 Market Size Forecast by Product (2019-2025)
    • 13.10 Market Size Forecast by Application (2019-2025)

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 12.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Precision cancer tests encompass imaging and in vitro diagnostic products and procedures that directly detect malignancies in patient samples or in the patients themselves.
      In 2018, the global Precision Cancer Tests market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Precision Cancer Tests status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Precision Cancer Tests development in United States, Europe and China.

      The key players covered in this study
      Abbott
      BD
      Bio-Rad
      Cynvenio Biosystems
      Foundation Medicine
      Genomic Health
      Illumina
      Myriad Genetics
      NanoString Technologies
      QIAGEN
      Randox Laboratories
      Roche
      Philips
      Thermo Fisher Scientific

      Market segment by Type, the product can be split into
      Imaging
      In Vitro Diagnostic
      Others

      Market segment by Application, split into
      Cancer Research Centers
      Cancer Hospital
      Surgical Centers
      Clinics
      Others

      Market segment by Regions/Countries, this report covers
      United States
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Precision Cancer Tests status, future forecast, growth opportunity, key market and key players.
      To present the Precision Cancer Tests development in United States, Europe and China.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Precision Cancer Tests are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now